Open original FDA record ↗Recall record
- FDA identifier
- Z-2617-2026
- Company in FDA record
- DEPUY (IRELAND)
- FDA classification date
- Jun 29, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.
Source facts
- Action
- DePuy Synthes notified consignees on about 0519/2026 via email. Consignees were instructed to examine inventory and quarantine any affected units on hand, contact the DePuy Sunthes Sales Consultant or customer support to coordinate the return of affected units, complete and return the Business Response Form, forward the notification to anyone in each facility that needs to be informed, and if any of the affected units have been sold or transferred to contact that facility and provide the notification. Consignees were also requested to post a copy of the notification in a visible area for awareness and keep a copy for your records.
- Initiated
- 2026-05-19
- Root cause
- Under Investigation by firm
- Distribution
- Distribution to MN, NC, TX.
- Recall number
- Z-2617-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221000
- FDA classified
- 2026-06-29
- Recall event number
- 99078